DK3920891T3 - Hurtig desintegrerende cannabinoid-tabletter - Google Patents

Hurtig desintegrerende cannabinoid-tabletter Download PDF

Info

Publication number
DK3920891T3
DK3920891T3 DK20727578.5T DK20727578T DK3920891T3 DK 3920891 T3 DK3920891 T3 DK 3920891T3 DK 20727578 T DK20727578 T DK 20727578T DK 3920891 T3 DK3920891 T3 DK 3920891T3
Authority
DK
Denmark
Prior art keywords
fast disintegrating
cannabinoid tablets
cannabinoid
tablets
disintegrating
Prior art date
Application number
DK20727578.5T
Other languages
English (en)
Inventor
Heidi Ziegler Bruun
Dorte Schackinger Boesen
Bruno Provstgaard Nielsen
Original Assignee
Nordiccan As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/386,477 external-priority patent/US10925853B2/en
Priority claimed from CA3040513A external-priority patent/CA3040513C/en
Priority claimed from CA3040547A external-priority patent/CA3040547C/en
Priority claimed from CA3040532A external-priority patent/CA3040532C/en
Priority claimed from CA3065042A external-priority patent/CA3065042C/en
Priority claimed from US16/713,580 external-priority patent/US11633351B2/en
Application filed by Nordiccan As filed Critical Nordiccan As
Application granted granted Critical
Publication of DK3920891T3 publication Critical patent/DK3920891T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
DK20727578.5T 2019-04-17 2020-04-17 Hurtig desintegrerende cannabinoid-tabletter DK3920891T3 (da)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US16/386,477 US10925853B2 (en) 2019-04-17 2019-04-17 Oral cannabinoid tablet
CA3040513A CA3040513C (en) 2019-04-17 2019-04-17 An oral cannabinoid tablet
CA3040547A CA3040547C (en) 2019-04-17 2019-04-17 Cannabinoid lozenge formulation
CA3040532A CA3040532C (en) 2019-04-17 2019-04-17 Lozenge for improved delivery of cannabinoids
CA3065042A CA3065042C (en) 2019-12-13 2019-12-13 Fast disintegrating cannabinoid tablets
US16/713,580 US11633351B2 (en) 2019-12-13 2019-12-13 Fast disintegrating cannabinoid tablets
PCT/DK2020/050102 WO2020211915A1 (en) 2019-04-17 2020-04-17 Fast disintegrating cannabinoid tablets

Publications (1)

Publication Number Publication Date
DK3920891T3 true DK3920891T3 (da) 2024-03-18

Family

ID=70802555

Family Applications (1)

Application Number Title Priority Date Filing Date
DK20727578.5T DK3920891T3 (da) 2019-04-17 2020-04-17 Hurtig desintegrerende cannabinoid-tabletter

Country Status (12)

Country Link
EP (2) EP4268815A3 (da)
JP (1) JP7556882B2 (da)
CN (1) CN113784704A (da)
AU (1) AU2020258631B2 (da)
BR (1) BR112021020523A2 (da)
DK (1) DK3920891T3 (da)
ES (1) ES2975266T3 (da)
FI (1) FI3920891T3 (da)
MX (1) MX2021012712A (da)
PL (1) PL3920891T3 (da)
WO (1) WO2020211915A1 (da)
ZA (1) ZA202107389B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020412501A1 (en) * 2019-12-24 2022-08-18 Cannadol Pharmaceuticals Ltd Compositions comprising terpenes and their use in the treatment or alleviation of pain or anxiety
PH12022552454A1 (en) * 2020-04-14 2024-02-05 Janssen Biotech Inc Pharmaceutical composition for oral administration comprising aminopyrimidine derivative or pharmaceutically acceptable salt, hydrate, or solvate thereof
WO2022103638A1 (en) * 2020-11-16 2022-05-19 Orcosa Inc. Cannabinoids in the treatment of autism spectrum disorder
CN114748429A (zh) * 2020-12-29 2022-07-15 汉义生物科技（北京）有限公司 一种水溶性大麻素制剂及其制备方法
JP2023010677A (ja) * 2021-07-09 2023-01-20 株式会社東洋新薬 固形組成物
JP2023010676A (ja) * 2021-07-09 2023-01-20 株式会社東洋新薬 固形組成物
JP2026510058A (ja) * 2023-03-21 2026-03-27 フェルティン ファルマ アー／エス カンナビノイド自己乳化系
JP2025529608A (ja) * 2023-07-24 2025-09-09 ポビバ コーポレーション てんかんを処置する為の組成物及び方法
DK202330231A1 (en) * 2023-09-27 2025-04-10 Fertin Pharma As Cannabidiol for alleviating xerostomia
CN118021744A (zh) * 2024-02-05 2024-05-14 谛邈生物科技(北京)有限公司 一种大麻二酚型大麻素化合物冻干闪释片及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1361864T3 (da) 2001-02-14 2014-03-03 Gw Pharma Ltd Flyldende sprayformuleringer til bukkal indgivelse af cannabinoider
GB0320854D0 (en) 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
US9308175B2 (en) * 2006-09-15 2016-04-12 Echo Pharmaceuticals B.V. Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances
KR20160083132A (ko) * 2007-06-06 2016-07-11 바스프 에스이 급속 붕해 정제의 제조를 위한 제약 제제
US20090004248A1 (en) 2007-06-29 2009-01-01 Frank Bunick Dual portion dosage lozenge form
LT2280687T (lt) 2008-03-26 2019-08-26 Stichting Sanammad Kramtomosios gumos kompozicijos, apimančios kanabinoidus
CN102119034B (zh) * 2008-06-13 2013-05-22 大日本住友制药株式会社 在口腔中快速崩解的片剂和制备其的方法
KR20130076015A (ko) * 2011-12-28 2013-07-08 주식회사 삼양바이오팜 높은 경도를 갖는 속붕정 및 이의 제조 방법
EP2609912A1 (en) * 2011-12-30 2013-07-03 Deva Holding Anonim Sirketi Pharmaceutical combination of fingolimod and nabiximols
CA2845443A1 (en) 2014-03-04 2015-09-04 Pharmascience Inc. Orally disintegrating tablet of nabilone and method of manufacturing
AU2015292915B2 (en) 2014-07-21 2020-10-15 Pharmaceutical Productions, Inc. Solid dosage form composition for buccal or sublingual administration of cannabinoids
WO2016092539A1 (en) 2014-12-07 2016-06-16 One World Cannabis Ltd Use of cannabis to treat migraine
HK1247084A1 (zh) 2015-02-02 2018-09-21 APIRx Pharmaceuticals, LLC 大麻素和糖醇复合物，制备和使用的方法
US10765658B2 (en) 2016-06-22 2020-09-08 Mastix LLC Oral compositions delivering therapeutically effective amounts of cannabinoids
JP2019526541A (ja) 2016-08-03 2019-09-19 ゼルダ セラピューティクス オペレーションズ ピーティーワイ リミテッド 大麻組成物
AU2018216173A1 (en) * 2017-02-05 2019-08-08 CannTab Therapeutics Limited Flash-melt cannabinoid formulations
US10772837B2 (en) 2017-03-16 2020-09-15 CannTab Therapeutics, Ltd Modified release multi-layer tablet cannabinoid formulations
WO2018217803A2 (en) * 2017-05-22 2018-11-29 Growblox Life Sciences L.L.C. Myrcene-containing complex mixtures targeting trpv1
US20200397744A1 (en) * 2018-02-09 2020-12-24 Neutrisci International Inc. Compositions comprising co-crystals of stilbenoids and cannabinoids

Also Published As

Publication number Publication date
WO2020211915A1 (en) 2020-10-22
ES2975266T3 (es) 2024-07-04
FI3920891T3 (fi) 2024-03-19
EP4268815A2 (en) 2023-11-01
JP7556882B2 (ja) 2024-09-26
CN113784704A (zh) 2021-12-10
BR112021020523A2 (pt) 2021-12-07
MX2021012712A (es) 2021-11-12
AU2020258631B2 (en) 2023-11-02
ZA202107389B (en) 2025-04-30
EP3920891B1 (en) 2024-02-21
EP3920891A1 (en) 2021-12-15
EP4268815A3 (en) 2024-02-21
JP2022529037A (ja) 2022-06-16
AU2020258631A1 (en) 2021-10-28
PL3920891T3 (pl) 2024-05-20

Similar Documents

Publication Publication Date Title
DK3920891T3 (da) Hurtig desintegrerende cannabinoid-tabletter
IL288423A (en) Cannabinoid formulations
EP3843763A4 (en) IMPROVED CANNABINOID BIOAVAILABILITY
EP4007967A4 (en) Multiply-accumulate unit
JP1719667S (ja) ディスペンサー
EP3930851A4 (en) COMBINATION THERAPIES
EP3919491C0 (en) AKT INHIBITOR
DK3920890T3 (da) Oral cannabinoid-tablet
EP3965938A4 (en) SHREDDING DEVICE
EP3941635C0 (en) CRUSHER
EP4032455A4 (en) Cleaner
EP3784402C0 (de) Brechaggregat
EP3742771C0 (en) M2M SM-SR TO SM-DP NOTIFICATION
EP4006362A4 (en) HYDRAULIC UNIT
EP3989891C0 (en) CRYOCABIN LAYOUT
EP3912517C0 (en) FRAME
EP3702039C0 (en) Crusher
EP3960060A4 (en) CLEANING DEVICE
DK3738452T3 (da) Fordamper
EP3755840A4 (en) REFINER SEGMENT
EP3682831C0 (en) CRYOGENIC APPLICATOR
EP4004280C0 (de) Presseneinheit
EP3930844A4 (en) EXTRACELLULAR MATRIX MODULATING AGENT
EP3825007A4 (en) MILL
EP3934901C0 (en) ADVANCED COMPACTOR/GRINDER